Benefits of insulin glargine/lixisenatide fixed-ratio combination for patients inadequately controlled on premixed insulin and oral agents
Naslov
Benefits of insulin glargine/lixisenatide fixed-ratio combination for patients inadequately controlled on premixed insulin and oral agents
Identifikator
/unibl/sci/idNaucniRad:28718
Tip
Pronađite slične unoseConference Paper
Datum
Pronađite slične unose2021-09
Bibliografski citat
I. Risović, M. Bojic, D. Djekic, Benefits of insulin glargine/lixisenatide fixed-ratio combination for patients inadequately controlled on premixed insulin and oral agents, Diabetologia 64, 1–380 (2021), Sep, 2021
Prezentovano
57 th EASD
Je dio
Diabetologia 64, 1–380 (2021)
Lista autora
Position: 19884 (32 views)